Cytomab 500 mg Injection
  1. Home
  2. Pharma Products
  3. Alkem Laboratories Ltd
  4. Cytomab 500 mg Injection

Cytomab 500 mg Injection

Cytomab 500 mg Injection contains rituximab, a monoclonal antibody medicine used to treat certain blood cancers and immune-related conditions. It is supplied as a 500 mg/50 mL injection for intravenous infusion. The medicine targets CD20-positive B cells and is administered under medical supervision.

BUY NOW

Category

Rituximab binds to the CD20 antigen found on certain B lymphocytes and helps reduce abnormal or unwanted B-cell activity. Cytomab 500 mg Injection may be used in treatment protocols for non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as selected autoimmune conditions. The dose and infusion schedule depend on the condition being treated and the prescribed clinical protocol. Treatment should be administered and monitored by qualified healthcare professionals in an appropriate medical setting.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Concentration 500 mg/50 mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 1 Vial of 50 mL

Product Also Known As

Cytomab 500 mg Injection, Rituximab 500 mg Injection, Rituximab 500 mg/50 mL Injection, Cytomab Rituximab Infusion, Anti-CD20 Monoclonal Antibody Injection, Rituximab Cancer Treatment Injection